Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M
Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Japan.
Blood. 1997 Jul 15;90(2):526-34.
Chromosome rearrangement of 14q32.33 has recurrently occurred with variable partner sites, including 11q13.3, 8q24.1, 18q21.3, and 6p21.1 in multiple myeloma (MM). To assess the actual incidence of 14q32.33 translocation and to elucidate its implication in the pathogenesis of MM, we studied 42 patients with MM, plasma cell leukemia, or plasmacytoma and 5 with monoclonal gammopathy with undetermined significance (MGUS) by G-banding and molecular cytogenetic methods. Using double-color fluorescence in situ hybridization (DCFISH) with 2 Ig heavy chain (IgH) gene probes, a yeast artificial chromosome (YAC) clone containing variable region, and a phage clone containing gamma constant region, 14q32.33 translocation was detected as split signals of the IgH gene in 31 patients with plasma cell malignancies and 3 with MGUS. In contrast, of 40 patients who were assessed by G-banding, 3 (7.5%) showed the 14q+ chromosome. DCFISH detected a split of the IgH gene on interphase nuclei in 34 (73.9%) of 46 patients analyzed, whereas on metaphase spreads, it was in 22 (51.2%) of 43 patients analyzed. Interphase DCFISH was particularly useful to detect 14q32.33 translocation in 17 (65.4%) of 26 patients with normal karyotypes. Donor sites were identified in 11 of 22 patients demonstrated as carrying 14q32.33 translocation by metaphase FISH. Chromosome t(11;14)(q13.3; q32.33) was detected in 5 patients, t(8;14)(q24.1;q32.33) in 2, t(14;18)(q32.33;q21.3) in 2, and t(7;14)(q32.1;q32.33) in 1. A complex 14q32.33 translocation involving 3q and 16q24 was detected in 1 patient. Myeloma cells with t(7;14) showed myelomonocytoid surface antigen. Because rearrangements of 14q32.33 were closely associated with translocation of proto-oncogenes into the IgH gene, our findings indicate that 14q32.33 translocation with various partner chromosomes is a critical event in the pathogenesis of MM and MGUS.
在多发性骨髓瘤(MM)中,14q32.33染色体重排经常发生,其伙伴位点多变,包括11q13.3、8q24.1、18q21.3和6p21.1。为了评估14q32.33易位的实际发生率,并阐明其在MM发病机制中的意义,我们采用G显带和分子细胞遗传学方法,研究了42例MM、浆细胞白血病或浆细胞瘤患者以及5例意义未明的单克隆丙种球蛋白病(MGUS)患者。使用双色荧光原位杂交(DCFISH)技术,以2个免疫球蛋白重链(IgH)基因探针、1个含可变区的酵母人工染色体(YAC)克隆和1个含γ恒定区的噬菌体克隆进行检测,结果在31例浆细胞恶性肿瘤患者和3例MGUS患者中,检测到14q32.33易位表现为IgH基因的分裂信号。相比之下,在40例经G显带评估的患者中,有3例(7.5%)显示14q+染色体。DCFISH在46例分析患者中的34例(73.9%)间期核中检测到IgH基因分裂,而在中期染色体上,43例分析患者中有22例(51.2%)检测到。间期DCFISH对于检测26例核型正常患者中的17例(65.4%)的14q32.33易位特别有用。在22例经中期荧光原位杂交(FISH)证实携带14q32.33易位的患者中,有11例确定了供体位点。检测到5例患者存在染色体t(11;14)(q13.3; q32.33),2例存在t(8;14)(q24.1;q32.33),2例存在t(14;18)(q32.33;q21.3),1例存在t(7;14)(q32.1;q32.33)。在1例患者中检测到涉及3q和16q24的复杂14q32.33易位。携带t(7;14)的骨髓瘤细胞显示髓单核细胞样表面抗原。由于14q32.33重排与原癌基因易位至IgH基因密切相关,我们的研究结果表明,14q32.33与各种伙伴染色体的易位是MM和MGUS发病机制中的关键事件。